Advanced Biomed Inc.
ADVB Nasdaq
SEC CIK 1941029
Follow Advanced Biomed
Weekly email: filings, results
Net income
−$989.1K
−155.6% vs same quarter last year
EPS, diluted
−$0.60
−66.7% vs same quarter last year
Operating cash flow
−$171.5K
+71.9% vs same quarter last year
Operating income
−$973.9K
−561.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY26 | $6.7M |
| FY25 | −$3.3M |
| FY24 | −$2.8M |
| FY23 | - |